Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.
M E Trulson, A D Stark, B L Jacobs
European Journal of Pharmacology July 15, 1977 DOI: 10.1016/0014-2999(77)90097-8 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal experimental study Peer reviewed |
|---|---|
| Population | Rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway |
| Interventions | LSD BOL STP Mescaline DMT 5-M-DMT Tryptamine Scopolamine Psilocin |
| Dose | LSD 0.1 and 0.2 mg/kg; BOL 5 mg/kg; STP 2 and 5 mg/kg; mescaline 50 and 100 mg/kg; DMT 10 and 20 mg/kg; 5-M-DMT 0.75 and 1.25 mg/kg; tryptamine 40 mg/kg; scopolamine 0.25 mg/kg; psilocin 1-20 mg/kg |
| Measures | turning behavior |
| Key findings | LSD produced strong contralateral turning (potent dopamine receptor agonist) and BOL was a weak agonist, while STP and mescaline produced significant ipsilateral turning (moderate dopamine-releasing action). DMT, 5-M-DMT, and psilocin showed weak or no significant turning. The authors propose that serotonin system inactivation may be necessary and sufficient for hallucinogenesis, with dopamine receptor activation possibly influencing hallucinogen potency. |
Abstract
The dopaminergic actions of various hallucinogenic drugs were assessed by examining their effects on turning behavior in rats with unilateral 6-hydroxydopamine lesions of the nigro-striatal pathway. LSD (0.1 and 0.2 mg/kg) produced strong contralateral turning, indicating that it is a potent dopamine receptor agonist, while BOL (5 mg/kg), a non-hallucinogenic congener of LSD, was found to be a weak dopamine receptor agonist. STP (2 and 5 mg/kg) and mescaline (50 and 100 mg/kg) produced significant ipsilateral turning, indicating that these compounds have a moderate dopamine-releasing action. DMT (10 and 20 mg/kg) and 5-M-DMT (0.75 and 1.25 mg/kg) produced weak ipsilateral turning, which was not significantly different from that produced by the nonhallucinogenic compounds tryptamine (40 mg/kg) or scopolamine (0.25 mg/kg). Psilocin (1-20 mg/kg) produced no significant turning in either direction. These data, in conjunction with previous studies, indicate that while inactivation of the brain serotonin system may be a necessary and sufficient condition for hallucinogenesis, the ability to activate dopamine receptors may be an important factor in determining the potency of hallucinogens.
Citations in the library
Cited by 14
- Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT) ACS Chemical Neuroscience July 23, 2018
- Dreams, Hallucinogenic Drug States, and Schizophrenia: A Psychological and Biological Comparison Schizophrenia Bulletin 1983
- Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide. Proceedings of the National Academy of Sciences December 1, 1977
- Dissociations Between the Effects of LSD on Behavior and Raphe Unit Activity in Freely Moving Cats Science August 3, 1979
- Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids TemaNord May 19, 2009
and 9 more in the library
Cites 7
- Lysergic Acid Diethylamide: Sensitive Neuronal Units in the Midbrain Raphe Science August 16, 1968
- 2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug Science November 3, 1967
- Lysergic Acid Diethylamide (LSD-25): I. Physiological and Perceptual Responses The Journal of Psychology 1955
- Studies on Lysergic Acid Diethylamide (LSD-25) A M A Archives of Neurology & Psychiatry November 1, 1956
- An Animal Behavior Model for Studying the Actions of LSD and Related Hallucinogens Science November 12, 1976
and 2 more in the library